Evidence map›Paper›PMID 35693053›Full record

ArticleLe infezioni in medicina2022

Thoracic aorta graft infection by avibactam-resistant KPC-producing

Alessandra Belati, Roberta Novara, Davide Fiore Bavaro, Andrea Procopio, Cecilia Fico, Lucia Diella, Federica Romanelli, Stefania Stolfa, Adriana Mosca, Francesco Di Gennaro and 1 more

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Le infezioni in medicina, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alessandra BelatiClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Roberta NovaraClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Davide Fiore BavaroClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Andrea ProcopioClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Cecilia FicoClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Lucia DiellaClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Federica RomanelliMicrobiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Stefania StolfaMicrobiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Adriana MoscaMicrobiology and Virology Unit, University of Bari, University Hospital Policlinico, Bari, Italy.
Francesco Di GennaroClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
Annalisa SaracinoClinic of Infectious Diseases, University of Bari, University Hospital Policlinico, Bari, Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meropenem/vaborbactam (M/V) is a new carbapenem-carbapenemase inhibitor combination drug active against extensively drug resistant Gram-negative pathogens. Studies about its efficacy and place in therapy are limited in "real-life" and no data are available for deep site infections, like vascular graft infections. We present a case of a patient successfully treated with M/V for a thoracic aorta graft infection, placed for a traumatic penetrating aortic ulcer, due to an extensively KPC-producing

Indexed as

antimicrobial resistancehospital acquired infectionsKPC-Klebsiella pneumoniaemeropenem/vaborbactamthoracic aorta graft infection

Identifiers

PMID35693053
PMCPMC9177178
OpenAlexW4285742247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.